Generic Bortezomib 3.5 mg injection is used in the treatment of multiple myeloma and mantle-cell lymphoma. It shows its working by stopping or slowing down the growth of cancer cells. Your doctor will decide what dose is necessary and how often you need to take it. Taking it in the wrong way or taking too much can cause severe side effects.
How To Use Bortezomib Injection
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
How Bortezomib 3.5 mg Works
Bortezomib 3.5 mg Injection is an anti-cancer medication. It works by blocking or slowing the breakdown of proteins in cells. As a result, there is an increase in the number of proteins in the cancer cells, leading to death.
Bortezomib Injection Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Generic Bortezomib
Low blood platelets
Fatigue
Peripheral neuropathy (tingling and numbness of feet and hand)
Psychiatric disturbances
Nausea
Vomiting
Loss of appetite
Fever
Anemia (low number of red blood cells)
Diarrhea
Decreased appetite
Decreased white blood cell count (neutrophils)
Constipation
Bortezomib 3.5 mg Dosage
Missed Dose
It is essential to get each Bortezomib dose of this medication as scheduled. If you miss a Bortezomib dose, ask your doctor or pharmacist right away for a new dosing schedule.
Storage
Not applicable. This medication is given in a clinic and will not be stored at home.
FAQs
If I have multiple myeloma, can I receive Bortezomib after a stem cell transplant?
Yes. The FDA has approved Bortezomib for people with newly diagnosed as well as relapsed multiple myeloma, including people who previously received Bortezomib. Talk with your doctor or healthcare team about whether Bortezomib may be right for you.
How often should I receive generic Bortezomib?
Your treatment schedule will vary depending on your diagnosis and treatment regimen.
How long should I take Bortezomib if I have previously untreated multiple myeloma?
Bortezomib is given twice a week for 2 weeks, followed by a 10-day rest period
This sequence is then repeated to make one 6-week cycle
